eagle, I wouldn't like to speculate on what sort of deals might arise as there are many options.
For all we know they could sell the rights of CVac for Ovarian in order to take the rest of the indications to market on their own. Combined, they are a much larger market than Ovarian, so would hate for them to just give them away.
big phamas and more mentioned at agm, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.5¢ | 28.8¢ | $574.2K | 1.921M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 461775 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |